Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by JLGeminion Dec 24, 2010 9:29am

278 Views

Post# 17892449

RE: TSX Trading Summary 2010-12-23

Good information. Three days of data and the source of the buying support to keep the price up is obvious. I wish that we had another institutional buyer or two, or three, in the hunt. They will be jumping on board with the announcements of the completion of phase 1 of the pivotal trial and results from the small cell lung cancer studies. Who ever is buying now is taking advantage of a sleepy market.

Can you confirm that 1 Anonymous is the market maker for stock so it is not necessary to identify the company providing the service? It will vary from stock to stock.

Thank you again.

Bullboard Posts

Three stocks with strong income statements to buy right now